New Drug Approvals

RQ 00000010 for the treatment of GERD, functional dyspepsia and chronic constipation. December 3, 2015 - (0)

RQ 00000010 CAS 907607-22-1 Molecular Formula: C22H27F3N2O6 Molecular Weight: 472.45479 g/mol HSMMHNBGQLGCBY-UHFFFAOYSA-N; RaQualia Pharma Inc Raqualia Pharma Inc. PFIZER INNOVATOR RQ-00000010; RQ-10 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid ΦirΦfff^fΣ^^-TrifluoroethoxyVi.a-benzisoxazol-S-vnoxylmethvπpiperidin-i-vπmethylltetrahydro-2H-pyran-4-carboxylic acid 4-[[4-[[4-(2,2,2-trifluoroethoxy)-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-yl]methyl]oxane-4-carboxylic acid PHASE 1 for the treatment of GERD, functional dyspepsia and chronic constipation. Useful for treating diseases mediated by 5-HT4 receptor activity eg such as gastroesophageal […]
Lefucoxib (乐福昔布) December 3, 2015 - (0)
DRL 17822 from Reddy US Therapeutics/Dr Reddy’s December 3, 2015 - (0)
WO 2015177807, New patent on AVANAFIL by Wanbury November 30, 2015 - (0)
Pfizer’s PF 04991532 a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus November 27, 2015 - (2)

Mobile Site | Full Site